From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

Survival of myeloma patients has greatly improved with the use of autologous stem cell transplantation and novel agents, such as proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies. Compared to bortezomib- and lenalidomide-based regimens alone, the addition of high-dose melphalan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Gay, Francesca, Engelhardt, Monika, Terpos, Evangelos, Wäsch, Ralph, Giaccone, Luisa, Auner, Holger W., Caers, Jo, Gramatzki, Martin, van de Donk, Niels, Oliva, Stefania, Zamagni, Elena, Garderet, Laurent, Straka, Christian, Hajek, Roman, Ludwig, Heinz, Einsele, Herman, Dimopoulos, Meletios, Boccadoro, Mario, Kröger, Nicolaus, Cavo, Michele, Goldschmidt, Hartmut, Bruno, Benedetto, Sonneveld, Pieter
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792264/
https://ncbi.nlm.nih.gov/pubmed/29217780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.174573
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados